This poster, presented at the 2021 ICAR virtual meeting, shows results from experiments to investigate a novel DHODH inhibitor as a potential treatment for COVID-19
ICAR 2021 Poster: The dihydroorotate dehydrogenase (DHODH) inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines implicated in COVID-19 disease and is currently being evaluated in the FITE19 clinical trial in hospitalized patients
GL-CORP-0207 | June 2021
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.